Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CHLORHEXIDINE 0.12% RINSE

Chlorhexidine Gluconate Oral Rinse
$0.0073per ML

Strength

1.2 mg/mL

Manufacturer

Rising Pharma Holdings Inc.

NDC

16571012848

Classification

Generic

Dosage Form

SOLUTION

Route

DENTAL

Last Updated

4/22/2026

Active Ingredients

CHLORHEXIDINE GLUCONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA075561

On Market Since

7/27/2023

Pharmacological Classes

Decreased Cell Wall Integrity

Price History

1W

0.0%

1M

+0.7%

3M

0.0%

6M

-3.2%

1Y

-4.0%

3Y

N/A

5Y

N/A

All

+39.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GNP HAND SOAP 2% CLEANSER
Generic
46122065936•AmerisourceBergen
$0.0069
per ML
CHLORHEXIDINE 0.12% RINSE
Generic
00116200116•Xttrium Laboratories, Inc.
$0.0073
per ML
CHLORHEXIDINE 0.12% RINSE
Generic
62135064947•Chartwell RX LLC
$0.0073
per ML
CHLORHEXIDINE 0.12% RINSE
Generic
00121089316•PAI Holdings LLC
$0.0074
per ML
CHLORHEXIDINE 0.12% RINSE
Generic
00116200104•Xttrium Laboratories, Inc.
$0.0168
per ML
CHLORHEXIDINE 4% LIQUID
Generic
16571011148•Rising Pharma Holdings Inc.
$0.0193
per ML
GNP ANTISEPTIC SKIN CLEANSR 4%
Generic
46122013743•AmerisourceBergen
$0.0193
per ML
BETASEPT 4% SURGICAL SCRUB
Generic
67618020016•Atlantis Consumer Healthcare, Inc.
$0.0193
per ML
HM ANTISEPTIC SKIN CLEANSER 4%
Generic
62011023701•Strategic Sourcing Services LLC
$0.0289
per ML
CHLORHEXIDINE 4% LIQUID
Generic
16571011124•Rising Pharma Holdings Inc.
$0.0295
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy